Eight immune-related hub-genes were identified to be molecular signatures in the immunomodulatory subtype of TNBC, which may provide therapeutic targets for the treatment of patients with breast cancer.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2020) studied this question.